Medicamen Biotech forms committee for preferential issue

Medicamen Biotech forms committee for preferential issue. The company has constituted a Preferential Issue Committee as per SEBI (Listing) Regulations. This step follows regulatory norms under Regulation 30 for potential fund raising. No financial details or issue size disclosed yet.

📊 STOCKS: MEDICAMEN | 🏢 SECTOR: Pharma | #LOWIMPACT #CorporateAction